FDA NDC Directory · JSON-LD · Markdown

PERJETA

NDC 50242-145 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic namePertuzumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA125409
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsPERTUZUMAB (30 mg/mL)
Marketing started20120608
Package count1

External sources

Source: openFDA. Public-domain (CC0).